Targeting Autocrine CCL5-CCR5 Axis Reprograms Immunosuppressive Myeloid Cells and Reinvigorates Antitumor Immunity.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Cancer Research

• Publication date

  2017-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-16-2913PMID 28416485PMCID PMC5484057
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beyond immune density: critical role of spatial heterogeneity in estrogen receptor-negative breast cancer

  2015cited by this paper
• Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.

  2015cited by this paper
• Beyond immune density: critical role of spatial heterogeneity in estrogen receptor-negative breast cancer

  2015cited by this paper
• T-cell exhaustion in the tumor microenvironment

  2015cited by this paper
• Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected.

  2015cited by this paper
• Signaling pathways involved in MDSC regulation.

  2014cited by this paper
• Bone marrow endothelium-targeted therapeutics for metastatic breast cancer.

  2014cited by this paper
• The cellular and molecular origin of tumor-associated macrophages

  2014cited by this paper
• A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice

  2014cited by this paper
• The potential to target CCL5/CCR5 in breast cancer

  2014cited by this paper
• Tumor-associated macrophages: from mechanisms to therapy.

  2014cited by this paper
• Myeloid-cell differentiation redefined in cancer

  2013cited by this paper
• Abstract 1515: Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer.

  2013cited by this paper
• The TGF-β-Smad3 pathway inhibits CD28-dependent cell growth and proliferation of CD4 T cells

  2013cited by this paper
• Myeloid-Derived Suppressor Cells Attenuate TH1 Development through IL-6 Production to Promote Tumor Progression

  2013cited by this paper
• Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences

  2013cited by this paper
• CCL5 and CCR5 Interaction Promotes Cell Motility in Human Osteosarcoma

  2012cited by this paper
• Characterization of the nature of granulocytic myeloid‐derived suppressor cells in tumor‐bearing mice

  2012cited by this paper
• Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells.

  2012cited by this paper
• Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer

  2012cited by this paper
• Targeting Costimulatory Molecules to Improve Antitumor Immunity

  2012cited by this paper
• A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells

  2012cited by this paper
• Coordinated regulation of myeloid cells by tumours

  2012cited by this paper
• Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer

  2012cited by this paper
• Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells

  2011cited by this paper
• Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation.

  2011cited by this paper
• CD11b+, Ly6G+ Cells Produce Type I Interferon and Exhibit Tissue Protective Properties Following Peripheral Virus Infection

  2011cited by this paper
• Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.

  2010cited by this paper
• FcRgamma activation regulates inflammation-associated squamous carcinogenesis.

  2010cited by this paper
• Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted into Immunogenic APCs with the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine1

  2009cited by this paper
• CCL5 increases lung cancer migration via PI3K, Akt and NF-kappaB pathways.

  2009cited by this paper
• Myeloid-derived suppressor cells as regulators of the immune system

  2009cited by this paper
• Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN.

  2009cited by this paper
• Potential differentiation of tumor bearing mouse CD11b+Gr-1+ immature myeloid cells into both suppressor macrophages and immunostimulatory dendritic cells.

  2009cited by this paper
• Concomitant expression of the chemokines RANTES and MCP-1 in human breast cancer: a basis for tumor-promoting interactions.

  2008cited by this paper
• Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications.

  2008cited by this paper
• The terminology issue for myeloid-derived suppressor cells.

  2007cited by this paper
• CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells.

  2006cited by this paper
• Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.

  2005cited by this paper
• Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis.

  2004cited by this paper
• Chemokines: attractive mediators of the immune response.

  2003cited by this paper
• Blood monocytes consist of two principal subsets with distinct migratory properties.

  2003cited by this paper
• Immunity to cancer: attack and escape in T lymphocyte–tumor cell interaction

  2002cited by this paper
• An induced Ets repressor complex regulates growth arrest during terminal macrophage differentiation.

  2002cited by this paper
• Myeloid Suppressor Lines Inhibit T Cell Responses by an NO-Dependent Mechanism1

  2002cited by this paper
• RANTES Activates Jak2 and Jak3 to Regulate Engagement of Multiple Signaling Pathways in T Cells*

  2001cited by this paper
• Chemokine receptor desensitization in tumor-bearing mice.

  2001cited by this paper
• Tumor-Infiltrating Macrophages Induce Apoptosis in Activated CD8+ T Cells by a Mechanism Requiring Cell Contact and Mediated by Both the Cell-Associated Form of TNF and Nitric Oxide1

  2001cited by this paper
• Mouse 4T1 Breast Tumor Model

  2000cited by this paper
• Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease

  1992cited by this paper

• Epithelial-mesenchymal transition and tumor-associated macrophage axis in metastatic breast cancer: converging mechanisms and therapeutic perspectives.

  2025cites this paper
• Circular RNA CLASP1 modulates the GLI1/SNAIL axis and enhances macrophage polarization in breast cancer

  2025cites this paper
• Unraveling the alterations and biomarkers in the tumor microenvironment in lung adenocarcinoma metastases and their indications for therapeutic response and prognosis

  2025cites this paper
• Histone deacetylase HDAC7 restricts CD8 + T cell tumor infiltration and limits immunotherapy sensitivity in bladder cancer: reversal by pinocembrin

  2025cites this paper
• A silence catalyst: CCL5-mediated intercellular communication in cancer

  2025influential citation
• IFI30 promotes tumor-associated macrophage infiltration via activation of the ATF3-CCL5 axis in breast cancer

  2025cites this paper
• CCR1hi/CCL5hi macrophage-mediated CCL5hi T cell chemotaxis in salivary gland aggravates Sjögren's syndrome.

  2025cites this paper
• Neutrophils in cancer: from immune defense to tumor promotion

  2025cites this paper
• New Insights into Monocyte-Derived Macrophages in Glioblastoma

  2025cites this paper
• Targeting immune microenvironment in cervical cancer: current research and advances

  2025cites this paper
• The Role of Obesity in the Regulation of Immunosuppressive Cell Infiltration and Immunosurveillance in Cancers

  2025cites this paper
• Combining BET inhibition with SMAC mimetics restricts tumor growth and triggers immune surveillance in preclinical cancer models

  2025cites this paper
• Targeting Myeloid Cells for Cancer Immunotherapy

  2025cites this paper
• CCL5: An emerging key target and progress in the targeted therapy of hepatocellular carcinoma.

  2025cites this paper
• C-C motif glycoprotein ligand 5 (CCL5) and its GPCR CCR5: Macromolecular game-changers in cancer biology.

  2025cites this paper
• Could Silent Inflammation Originating in Jawbone Cavitations Play a Role in Activating the CCL5/CCR5 Axis in Female Breast Cancer? A Diagnostic and Therapeutic Gap in Osteoimmunological Interactions

  2025cites this paper
• Chemokine-chemokine receptor networks in conventional type I dendritic cells: an opportunity to prime and boost anticancer immunity.

  2025cites this paper
• The hypoxic ECM and neutrophils in MIBC immunotherapy resistance.

  2025cites this paper
• Targeting the CCL5/CCR5 axis in tumor-stromal crosstalk to overcome cisplatin resistance in neuroendocrine prostate cancer

  2025cites this paper
• Emerging Role of MDSCS as Novel Biomarkers and Therapeutic Targets for Cancer Immunotherapy

  2025cites this paper
• Exosomes as drug delivery systems in glioma immunotherapy

  2024cites this paper
• Complex role of neutrophils in the tumor microenvironment: an avenue for novel immunotherapies

  2024cites this paper
• Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma

  2024cites this paper
• Glutathione Dynamics in the Tumor Microenvironment: A Potential Target of Cancer Stem Cells and T Cells

  2024cites this paper
• CD74 is a potential biomarker predicting the response to immune checkpoint blockade

  2024cites this paper
• CDDP-induced desmoplasia-like changes in oral cancer tissues are related to SASP-related factors induced by the senescence of cancer cells.

  2024cites this paper
• Nanoparticle-Mediated Immunotherapy in Triple-Negative Breast Cancer

  2024cites this paper
• Circadian control of tumor immunosuppression affects efficacy of immune checkpoint blockade

  2024cites this paper
• Immune Cell Migration to Cancer

  2024cites this paper
• Transcriptome Deconvolution Reveals Absence of Cancer Cell Expression Signature in Immune Checkpoint Blockade Response

  2024cites this paper
• Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives

  2024cites this paper
• Neurogenesis-Associated Protein, a Potential Prognostic Biomarker in Anti-PD-1 Based Kidney Renal Clear Cell Carcinoma Patient Therapeutics

  2024cites this paper
• Translational Frontiers and Clinical Opportunities of Immunologically Fitted Radiotherapy

  2024cites this paper
• Low-dose radiotherapy synergizes with iRGD-antiCD3-modified T cells by facilitating T cell infiltration.

  2024cites this paper
• Immune landscape and response to oncolytic virus-based immunotherapy

  2024cites this paper
• CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma.

  2024cites this paper
• CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value

  2024cites this paper
• Multifaceted roles of neutrophils in tumor microenvironment.

  2024cites this paper
• The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy

  2024cites this paper
• Macrophages at the interface of the co-evolving cancer ecosystem.

  2023cites this paper
• Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond

  2023cites this paper
• The regulatory network of the chemokine CCL5 in colorectal cancer

  2023cites this paper
• A novel antagonist of the CCL5/CCR5 axis suppresses the tumor growth and metastasis of triple-negative breast cancer by CCR5-YAP1 regulation

  2023influential citation
• TIAM2S‐positive microglia enhance inflammation and neurotoxicity through soluble ICAM‐1‐mediated immune priming

  2023cites this paper
• A transcriptome-wide meta-analysis reveals lack of cancer-cell intrinsic determinants of response to immune checkpoint blockade

  2023cites this paper
• ZNF451 favors triple-negative breast cancer progression by enhancing SLUG-mediated CCL5 transcriptional expression.

  2023cites this paper
• A Cancer Prevention and Treatment Opportunity

  2023cites this paper
• Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy.

  2023cites this paper
• Cancer-Associated Adipocytes and Breast Cancer: Intertwining in the Tumor Microenvironment and Challenges for Cancer Therapy

  2023influential citation
• TGFβ1+CCR5+ neutrophil subset increases in bone marrow and causes age-related osteoporosis in male mice

  2023cites this paper
• Good CARMA: Turning bad tumor‐resident myeloid cells good with chimeric antigen receptor macrophages

  2023cites this paper
• Tumor-associated macrophages: an effective player of the tumor microenvironment

  2023cites this paper
• Breast cancer stem cells generate immune-suppressive T regulatory cells by secreting TGFβ to evade immune-elimination

  2023cites this paper
• Mesothelial cells with mesenchymal features enhance peritoneal dissemination by forming a protumorigenic microenvironment.

  2023cites this paper
• Current progress of immune checkpoint inhibitors for advanced colorectal cancer: concentrating on the efficacy improvement.

  2023cites this paper
• Innate immune deficiencies are associated with severity and poor prognosis in patients with COVID-19

  2022cites this paper
• Adipose Tissue-Derived CCL5 Enhances Local Pro-Inflammatory Monocytic MDSCs Accumulation and Inflammation via CCR5 Receptor in High-Fat Diet-Fed Mice

  2022cites this paper
• Single-cell transcriptome analysis of tumor immune microenvironment characteristics in colorectal cancer liver metastasis

  2022cites this paper
• Granulocytic MDSC with Deficient CCR5 Alleviates Lipogenesis and Inflammation in Nonalcoholic Fatty Liver Disease

  2022cites this paper
• Inflammation-Targeted Nanomedicine against Brain Cancer: From Design Strategies to Future Developments.

  2022cites this paper
• Pharmacological modulation of myeloid-derived suppressor cells to dampen inflammation

  2022cites this paper
• Metastasis Role of myeloid cells in the tumor microenvironment

  2022cites this paper
• Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches.

  2022cites this paper
• The complex role of tumor-infiltrating macrophages

  2022cites this paper
• Myeloid-derived suppressor cells in cancer

  2022cites this paper
• Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets

  2022cites this paper
• Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good

  2022cites this paper
• Tumor-Mediated Neutrophil Polarization and Therapeutic Implications

  2022cites this paper
• CCL5 Deficiency Enhanced Cryo–Thermal-Triggered Long-Term Anti-Tumor Immunity in 4T1 Murine Breast Cancer

  2022cites this paper
• CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor

  2022cites this paper
• Myeloid Immune Cells CARrying a New Weapon Against Cancer

  2021cites this paper
• Monocyte Regulation in Homeostasis and Malignancy.

  2021cites this paper
• Leronlimab, a humanized monoclonal antibody to CCR5, blocks breast cancer cellular metastasis and enhances cell death induced by DNA damaging chemotherapy

  2021cites this paper
• Bioinformatics and immunohistochemistry analyses of expression levels and clinical significance of CXCL2 and TANs in an oral squamous cell carcinoma tumor microenvironment of Prophyromonas gingivalis infection

  2021cites this paper
• Tumor-related stress regulates functional plasticity of MDSCs.

  2021cites this paper
• Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates anti-tumor immune responses.

  2021cites this paper
• CCR5 is a potential therapeutic target for cancer

  2021cites this paper
• Suppressive Myeloid Cells Shape the Tumor Immune Microenvironment.

  2021cites this paper
• Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLC

  2021cites this paper
• Innate immune deficiencies in patients with COVID-19

  2021cites this paper
• Construction of a risk map to understand the vulnerability of various types of cancer patients to COVID‐19 infection

  2021cites this paper
• Contribution of the tumor and obese microenvironment to triple negative breast cancer.

  2021cites this paper
• Macrophage-Based Approaches for Cancer Immunotherapy A C

  2021cites this paper
• Cancer stem cell–immune cell crosstalk in tumour progression

  2021cites this paper
• SLC7A2 deficiency promotes hepatocellular carcinoma progression by enhancing recruitment of myeloid-derived suppressors cells

  2021cites this paper
• Blocking the CCL5–CCR5 Axis Using Maraviroc Promotes M1 Polarization of Macrophages Cocultured with Irradiated Hepatoma Cells

  2021cites this paper
• Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation

  2021cites this paper
• Depiction of the genomic and genetic landscape identifies CCL5 as a protective factor in colorectal neuroendocrine carcinoma

  2021cites this paper
• CCL5/CCR5 axis in human diseases and related treatments

  2021cites this paper
• Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis

  2021cites this paper
• Chemokine-Directed Tumor Microenvironment Modulation in Cancer Immunotherapy

  2021cites this paper
• Bringing Macrophages to the Frontline against Cancer: Current Immunotherapies Targeting Macrophages

  2021cites this paper
• Macrophage-targeted nanomedicine for chronic diseases immunotherapy

  2021cites this paper
• Lysophosphatidic Acid Receptor 6 (LPAR6) Is a Potential Biomarker Associated with Lung Adenocarcinoma

  2021cites this paper
• Single-cell RNA-seq and chromatin accessibility profiling decipher the heterogeneity of mouse γδ T cells.

  2021cites this paper
• BMS-813160: A Potent CCR2 and CCR5 Dual Antagonist Selected as a Clinical Candidate.

  2021cites this paper
• Myeloid-Derived Suppressor Cells in Prostate Cancer: Present Knowledge and Future Perspectives

  2021cites this paper
• RNA Interference and CRISPR Technologies: Technical Advances and New Therapeutic Opportunities

  2020cites this paper
• Cancer immunology of cutaneous melanoma: a systems biology approach

  2020cites this paper
• Macrophage-Based Approaches for Cancer Immunotherapy

  2020cites this paper